NCT05742568 2025-07-03
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
Xijing Hospital of Digestive Diseases
Phase 4 Completed
Clinical Trials
8 trialsNCT06168084 2025-07-03
Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT04678492 2023-01-31
Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT04697186 2023-01-31
Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT03609892 2019-08-30
Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT00002682 2018-10-24
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01967758 2018-08-17
Phase I Study of Safety and Immunogenicity of ADU-623
Providence Health & Services
Phase 1 Completed
NCT00201422 2016-03-28
Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma
National Health Research Institutes, Taiwan
Phase NA Completed